Elanco Third-Quarter Revenue Rises 11% to $1.265 Billion: Net Income of $18 Million and EPS of $0.04, With Adjusted Net Income of $136 Million and Adjusted EPS of $0.27
Elanco Animal Health Incorporated (NYSE: ELAN), based in Indianapolis, Indiana, on November 6 reported financial results for the third quarter of 2026. Revenue was $1.265 billion, an increase of 11% year over year, with 9% organic constant-currency growth. Reported net income was $18 million, compared with a net loss of $34 million in the same period of 2025; adjusted net income was $136 million; and adjusted EBITDA was $243 million, with an adjusted EBITDA margin of 19.5% as presented in the release. Reported diluted EPS was $0.04, compared with a loss of $0.07 per diluted share a year earlier, and adjusted EPS was $0.27. The net leverage ratio stood at 2.9 times adjusted EBITDA.
Alongside the results, the company raised its full-year 2026 guidance, provided guidance for the fourth quarter of 2026, and gave an early outlook for the full year 2027: full-year revenue guidance was raised to $5.155 billion to $5.18 billion, adjusted EBITDA guidance to $1.05 billion to $1.065 billion, adjusted EPS guidance to $1.17 to $1.20, and the innovation revenue target to $1.275 billion; the release notes that the full-year and fourth-quarter guidance reflects foreign exchange rates as of the end of October. Elanco hosted a webcast and conference call at 8:00 a.m. Eastern Time on November 6, at which executives reviewed the quarter's results, the fourth-quarter and full-year guidance and the early 2027 outlook.
All figures in this report are taken from the body of the company's earnings release and its summary tables; adjusted figures are the company's non-GAAP measures as presented alongside the reported figures.
(Source: Elanco Animal Health)
Source: Elanco Animal Health
Published by GSM · USA (original Chinese edition)
Photo: 图：Elanco 公司标志。公共领域，经 Wikimedia Commons。 / Photo: The Elanco company logo. Public domain, via Wikimedia Commons.
Aflac Reports Third-Quarter Net Earnings of $303 Million, or $0.61 per Share: Total Revenues Fell 31.0% to $3.271 Billion; Fourth-Quarter Dividend of $0.61 Declared2026-11-08
Mercer's Third-Quarter Net Loss Narrows to $59.2 Million: Revenue Falls About 4% to $440.7 Million as a Restructuring Support Deal Covers $1.275 Billion of Notes and $400 Million of New Capital2026-11-08